se ha leído el artículo
array:25 [ "pii" => "S1578219021001633" "issn" => "15782190" "doi" => "10.1016/j.adengl.2021.05.004" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "2582" "copyright" => "AEDV" "copyrightAnyo" => "2021" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:665-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0001731021000016" "issn" => "00017310" "doi" => "10.1016/j.ad.2019.07.021" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "2582" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:665-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR -Aparición de herpes zoster secundario a la aplicación de ingenol mebutato en gel: comunicación del primer caso europeo" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "665" "paginaFinal" => "666" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF -Herpes Zoster Triggered by Ingenol Mebutate Gel: First European Case Report" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Garayar Cantero, E. Manrique-Silva, E. Godoy-Gijón" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Garayar Cantero" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Manrique-Silva" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Godoy-Gijón" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219021001633" "doi" => "10.1016/j.adengl.2021.05.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021001633?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021000016?idApp=UINPBA000044" "url" => "/00017310/0000011200000007/v1_202107020537/S0001731021000016/v1_202107020537/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219021001645" "issn" => "15782190" "doi" => "10.1016/j.adengl.2021.05.005" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "2561" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2021;112:667-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>" "titulo" => "Acute Postinfection Pityriasis Rubra Pilaris: Excellent Response to Emollients and Topical Corticosteroids" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "667" "paginaFinal" => "668" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pitiriasis rubra pilaris aguda postinfecciosa: gran respuesta a emolientes y a corticosteroides tópicos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3097 "Ancho" => 1674 "Tamanyo" => 325556 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Initial clinical picture: multiple salmon-pink plaques on the trunk and both arms. B, Complete response after 4 weeks of topical corticosteroid treatment.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.S. Zegpi-Trueba, L. Navajas-Galimany, S. González, C. Ramírez-Cornejo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M.S." "apellidos" => "Zegpi-Trueba" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "Navajas-Galimany" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "González" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Ramírez-Cornejo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021001645?idApp=UINPBA000044" "url" => "/15782190/0000011200000007/v1_202107020822/S1578219021001645/v1_202107020822/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S1578219021001578" "issn" => "15782190" "doi" => "10.1016/j.adengl.2021.04.003" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "2598" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:663-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident’s Forum</span>" "titulo" => "RF-Prurigo Nodularis: Associations With Neoplasms, Recommendations for Additional Testing, and Novel Treatments" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "663" "paginaFinal" => "664" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-Prurigo nodular: asociación con neoplasias, pruebas complementarias y nuevos tratamientos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L. Serra-García, D. Morgado-Carrasco" "autores" => array:2 [ 0 => array:2 [ "nombre" => "L." "apellidos" => "Serra-García" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Morgado-Carrasco" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731021000934" "doi" => "10.1016/j.ad.2019.08.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021000934?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021001578?idApp=UINPBA000044" "url" => "/15782190/0000011200000007/v1_202107020822/S1578219021001578/v1_202107020822/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident's Forum</span>" "titulo" => "RF-Herpes Zoster Triggered by Ingenol Mebutate Gel: First European Case Report" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "665" "paginaFinal" => "666" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Garayar Cantero, E. Manrique-Silva, E. Godoy-Gijón" "autores" => array:3 [ 0 => array:4 [ "nombre" => "M." "apellidos" => "Garayar Cantero" "email" => array:1 [ 0 => "mariagarayar@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "E." "apellidos" => "Manrique-Silva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "E." "apellidos" => "Godoy-Gijón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Hospital Clínico Universitario de Valladolid, Valladolid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Fundación Instituto Valenciano de Oncología, Valencia, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Hospital Clínico de Salamanca, Salamanca, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-Aparición de herpes zoster secundario a la aplicación de ingenol mebutato en gel: comunicación del primer caso europeo" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Actinic keratosis (AK) is a premalignant skin lesion that can progress to squamous cell carcinoma. Ingenol mebutate (IM) gel is a widely used topical treatment for the management of nonhyperkeratotic AK. This gel has also been used off-label to treat actinic cheilitis.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Case Description</span><p id="par0010" class="elsevierStylePara elsevierViewall">An 85-year-old Caucasian man with a history of hypertension and dyslipidemia was referred to our clinic for asymptomatic scaly lesions on the scalp that had appeared 5 years earlier. Physical examination revealed multiple erythematous, scaly plaques (0.5–1 cm) on the surface of the scalp containing little infiltrate. Because the lesions were clinically compatible with AK the patient was prescribed 0.015% IM gel, to be applied once per day for 3 consecutive days. One week after treatment, the patient developed a painful skin rash consisting of multiple vesicular lesions located predominantly in the left cervical area compatible with herpes zoster (HZ). The lesion distribution suggested involvement of branches C2–C4 of the cervical plexus. Polymerase chain reaction (PCR) confirmed a diagnosis of varicella-zoster virus (VZV). Brivudine (125 mg/d) was prescribed for 7 days. The HZ lesions resolved without complications. Based on the location and timing of the lesions, reactivation of VZV was attributed to treatment with IM. Consequently, the Spanish Pharmacovigilance System for Medicinal Products for Human Use (SEFV-H) was informed about this side effect.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discussion</span><p id="par0015" class="elsevierStylePara elsevierViewall">Adverse skin reactions to IM include erythema, post-inflammatory hyperpigmentation, and residual scars, all of which are likely related to local inflammation caused by IM. Erosive pustular dermatosis of the scalp,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> bullous reactions,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> and squamous cell carcinoma<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> have been associated with IM treatment. To date, no cases of VZV reactivation associated with IM treatment have been described in Europe.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In August 2015, following reports of 20 such cases in the United States in the post-marketing phase, the Food and Drug Administration (FDA) included HZ as a possible adverse effect of IM, and added this information to the summary of product characteristics (SmPC). However, this adverse effect has not been included in the SmPC for IM in Europe.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The total number of recorded cases is not entirely clear, as some reported cases may have been due to herpes simplex virus (HSV) reactivation. While HSV latency can be mediated by distinct mechanisms, one gene implicated in this process is the latency-associated transcription (LAT) gene. Certain stimuli that inhibit the expression of this gene, including hypoxia and cellular apoptosis induced by IM or other topical treatments for AK, can induce transcription and reactivation of viral genes in certain patients.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Age and immune compromise are other known risk factors for VZV reactivation. Because patients with AK are generally over 60 years of age, the use of IM in this subgroup of patients could increase the risk of developing HZ.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusion</span><p id="par0035" class="elsevierStylePara elsevierViewall">To date, there have been no other reports in Europe of VZV reactivation in immunocompetent patients treated with IM gel. In cases in which a blistering reaction occurs after IM treatment, we believe it is important to perform a Tzank or PCR test, based on which an association with VZV or HSV can be ruled out. If VZV reactivation is confirmed, antiviral treatment should be started immediately to reduce the risk of late complications that can lead to high morbidity.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Conflicts of Interest</span><p id="par0040" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:2 [ "identificador" => "xpalclavsec1395167" "titulo" => "Palabras clave" ] 1 => array:2 [ "identificador" => "xpalclavsec1395166" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Case Description" ] 4 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 5 => array:2 [ "identificador" => "sec0020" "titulo" => "Conclusion" ] 6 => array:2 [ "identificador" => "sec0025" "titulo" => "Conflicts of Interest" ] 7 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1395166" "palabras" => array:3 [ 0 => "Ingenol mebutate" 1 => "Herpes zoster" 2 => "Herpes simplex virus" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Garayar Cantero M, Manrique-Silva E, Godoy-Gijón E. FR-Aparición de herpes zoster secundario a la aplicación de ingenol mebutato en gel: comunicación del primer caso europeo. Actas Dermosifiliogr. 2021;112:665–666.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of actinic cheilitis using ingenol mebutate gel: A report of seven cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Florez" 1 => "A. Batalla" 2 => "C. de la Torre" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/09546634.2016.1188196" "Revista" => array:6 [ "tituloSerie" => "J Dermatolog Treat." "fecha" => "2017" "volumen" => "28" "paginaInicial" => "149" "paginaFinal" => "151" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27241280" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erosive pustular dermatosis of the scalp following topical ingenol mebuate for actinic keratoses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Vaccaro" 1 => "F. Borgia" 2 => "L. Gasco" 3 => "S.P. Cannavo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Dermatol Ther." "fecha" => "2017" "volumen" => "30" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bullous reaction after application of a single dose ingenol mebutate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.L. Salskov-Iversen" 1 => "H.F. Lorentzen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Ugeskr Laeger." "fecha" => "2013" "volumen" => "175" "numero" => "49A" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Squamous cell carcinoma developed after ingenol mebutate theraphy: a possible consequence of the treatment?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Maglie" 1 => "V. Grandi" 2 => "V. Maio" 3 => "A. Pileri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.23736/S0392-0488.17.05564-X" "Revista" => array:6 [ "tituloSerie" => "G Ital Dermatol Venereol." "fecha" => "2018" "volumen" => "153" "paginaInicial" => "442" "paginaFinal" => "443" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29766707" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evasión de la respuesta inmune por virus herpes simplex" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.R. Retamal-Díaz" 1 => "P.A. Suazo" 2 => "I. Garrido" 3 => "A.M. Kalergis" 4 => "P.A. González" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4067/S0716-10182015000200013" "Revista" => array:6 [ "tituloSerie" => "Rev Chilena Infectol." "fecha" => "2015" "volumen" => "32" "paginaInicial" => "58" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25860047" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E. Stockfleth" 1 => "M. Bastian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1517/17425255.2013.733696" "Revista" => array:6 [ "tituloSerie" => "Expert Opin Drug Metab Toxicol." "fecha" => "2018" "volumen" => "9" "paginaInicial" => "1" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23189950" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011200000007/v1_202107020822/S1578219021001633/v1_202107020822/en/main.assets" "Apartado" => array:4 [ "identificador" => "34945" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Resident's Forum" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011200000007/v1_202107020822/S1578219021001633/v1_202107020822/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219021001633?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 13 | 12 | 25 |
2024 Octubre | 65 | 29 | 94 |
2024 Septiembre | 66 | 20 | 86 |
2024 Agosto | 86 | 60 | 146 |
2024 Julio | 55 | 24 | 79 |
2024 Junio | 79 | 35 | 114 |
2024 Mayo | 66 | 31 | 97 |
2024 Abril | 65 | 30 | 95 |
2024 Marzo | 57 | 33 | 90 |
2024 Febrero | 44 | 27 | 71 |
2024 Enero | 50 | 34 | 84 |
2023 Diciembre | 49 | 12 | 61 |
2023 Noviembre | 69 | 29 | 98 |
2023 Octubre | 57 | 23 | 80 |
2023 Septiembre | 57 | 31 | 88 |
2023 Agosto | 28 | 13 | 41 |
2023 Julio | 34 | 35 | 69 |
2023 Junio | 38 | 18 | 56 |
2023 Mayo | 39 | 19 | 58 |
2023 Abril | 31 | 22 | 53 |
2023 Marzo | 53 | 29 | 82 |
2023 Febrero | 32 | 20 | 52 |
2023 Enero | 38 | 27 | 65 |
2022 Diciembre | 45 | 40 | 85 |
2022 Noviembre | 28 | 26 | 54 |
2022 Octubre | 20 | 17 | 37 |
2022 Septiembre | 23 | 35 | 58 |
2022 Agosto | 24 | 38 | 62 |
2022 Julio | 23 | 51 | 74 |
2022 Junio | 24 | 60 | 84 |
2022 Mayo | 42 | 49 | 91 |
2022 Abril | 52 | 42 | 94 |
2022 Marzo | 57 | 60 | 117 |
2022 Febrero | 46 | 33 | 79 |
2022 Enero | 25 | 44 | 69 |
2021 Diciembre | 29 | 40 | 69 |
2021 Noviembre | 50 | 52 | 102 |
2021 Octubre | 39 | 73 | 112 |
2021 Septiembre | 41 | 53 | 94 |
2021 Agosto | 39 | 44 | 83 |
2021 Julio | 66 | 42 | 108 |
2021 Junio | 45 | 46 | 91 |
2021 Mayo | 42 | 23 | 65 |